What is RMBio?
RMBIO is a prominent producer of high-quality cell culture supplements, including essential components like sera, protein fractions, and culture media. The company's comprehensive product portfolio serves a wide array of critical sectors, encompassing cell culture, animal health, scientific research, pharmaceuticals, and diagnostics. RMBIO places a strong emphasis on product quality and unwavering reliability, ensuring all offerings undergo rigorous cell culture testing and are backed by ISIA certification for complete traceability. Their strategic objective is to maintain a consistent and timely supply chain for their diverse clientele, meeting the evolving demands of the life sciences industry.
How much funding has RMBio raised?
RMBio has raised a total of $1.1M across 1 funding round:
Private Equity
$1.1M
Private Equity (2015): $1.1M, investors not publicly disclosed
What's next for RMBio?
The substantial enterprise-level funding RMBio has attracted, particularly the recent strategic investment, signals a phase of accelerated growth and market penetration. This capital infusion is likely to fuel advancements in product development, expansion of manufacturing capabilities, and broader market outreach. RMBio's focus on quality and traceability positions it favorably to capitalize on the increasing demand for reliable biological reagents in research and biopharmaceutical production. The company is poised to further solidify its leadership in the cell culture supplement market.
See full RMBio company page
